(Q44542743)

4 December 2017

Ketodiet, physiological calcium intake and native vitamin D improve renal osteodystrophy (English)

1 reference

4 December 2017

0 references

2

1 reference

4 December 2017

M H Lafage

1

1 reference

PubMed ID

1453606

4 December 2017

A Fournier

series ordinal

3

1 reference

PubMed ID

1453606

4 December 2017

M Aparicio

series ordinal

4

1 reference

PubMed ID

1453606

4 December 2017

language of work or name

English

0 references

publication date

1 November 1992

1 reference

4 December 2017

1 reference

4 December 2017

42

1 reference

4 December 2017

5

1 reference

4 December 2017

1217-1225

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.1992.407

4 December 2017

0 references

cites work

Renal bone disease 1990: an unmet challenge for the nephrologist

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.407

7 January 2021

Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.407

7 January 2021

The effect of 1,25 dihydroxycholecalciferol on parathyroid hormone secretion by monolayer cultures of bovine parathyroid cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.407

7 January 2021

The Acute Effects of 1,25-Dihydroxycholecalciferol on Serum Immunoreactive Parathyroid Hormone in the Dog*

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.407

7 January 2021

Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.407

7 January 2021

Intestinal absorption of calcium and the effect of renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.407

7 January 2021

1,25(OH)2D3 administration in moderate renal failure: a prospective double-blind trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.407

7 January 2021

Deterioration of renal function during treatment of chronic renal failure with 1,25-dihydroxycholecalciferol

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.407

7 January 2021

Soft tissue calcification in pediatric patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.407

7 January 2021

Aluminum intoxication from aluminum-containing phosphate binders in children with azotemia not undergoing dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.407

7 January 2021

Non-aluminic adynamic bone disease in non-dialyzed uremic patients: a new type of osteopathy due to overtreatment?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.407

7 January 2021

Therapeutic effect of keto acids on renal osteodystrophy. A prospective controlled study

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.407

7 January 2021

Increase in serum bone gamma-carboxyglutamic acid protein with aging in women. Implications for the mechanism of age-related bone loss

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.407

7 January 2021

A competitive protein-binding assay for 25-hydroxycholecalciferol and 25-hydroxyergocalciferol in serum

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.407

7 January 2021

Histomorphometric analysis of dynamic parameters of trabecular bone formation in the iliac crest of normal British subjects

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.407

7 January 2021

Early dietary phosphorus restriction and calcium supplementation in the prevention of renal osteodystrophy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.407

7 January 2021

Reversal of hyperparathyroidism in severe uremics following very low-protein and low-phosphorus diet

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.407

7 January 2021

Phosphate retention and the genesis of secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.407

7 January 2021

On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.407

7 January 2021

Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.407

7 January 2021

Serum phosphate, parathyroid hormone and vitamin D metabolites in patients with chronic renal failure: effect of aluminum hydroxide administration

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.407

7 January 2021

Role of keto acids in the prophylaxis and treatment of renal osteopathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.407

7 January 2021

Optimal correction of acidosis changes progression of dialysis osteodystrophy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.407

7 January 2021

Osteomalacia and chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.407

7 January 2021

Does Strict Phosphorus Control Precipitate Renal Osteomalacia*

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.407

7 January 2021

Metabolites of vitamin D in human vitamin-D deficiency: effect of vitamin D3 or 1,25-dihydroxycholecalciferol

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.407

7 January 2021

Comparison of 1α-hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: Greater effect of 25-hydroxycholecalciferol on bone mineralization

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.407

7 January 2021

Adynamic Bone Disease in Uremia: May It Be Idiopathic? Is It an Actual Disease?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.407

7 January 2021

Vegetarian lifestyle and bone mineral density

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.407

7 January 2021

Comparison of intact, midregion, and carboxy terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.407

7 January 2021

https://api.fatcat.wiki/v0/release/wpstnkkwafeyhprxz6ro67q3cm

Identifiers

1 reference

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_wpstnkkwafeyhprxz6ro67q3cm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wpstnkkwafeyhprxz6ro67q3cm

30 July 2022

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/wpstnkkwafeyhprxz6ro67q3cm

30 July 2022